PRESS RELEASE published on 05/05/2025 at 12:15, 1 year 5 months ago Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL Sartorius Stedim Biotech SA makes declaration on number of shares and voting rights in the issued capital, meeting regulatory requirements. Details in the announcement Voting Rights Déclaration Shares Sartorius Stedim Biotech Regulatory Requirements
BRIEF published on 04/16/2025 at 14:46, 1 year 6 months ago Sartorius Stedim Biotech First Quarter 2025 Results EBITDA Sartorius Stedim Biotech Turnover 2025 Forecast Bioproduction
BRIEF published on 04/16/2025 at 07:05, 1 year 6 months ago Sartorius Stedim Biotech Reports Q1 2025 Results with Strong Growth Financial Performance Profitability Biotech Growth Q1 2025 Results Biomanufacturing Demand
PRESS RELEASE published on 04/16/2025 at 07:00, 1 year 6 months ago Sartorius Stedim Biotech publishes unaudited first quarter results for 2025 Sartorius Stedim Biotech reports strong first quarter results for 2025 with 10.4% sales revenue growth and a full-year sales revenue guidance increase of 7% Sartorius Stedim Biotech Biopharmaceutical Industry First Quarter Results Full-year Guidance Sales Revenue Growth
BRIEF published on 04/01/2025 at 10:36, 1 year 6 months ago Sartorius Stedim Biotech Announces Share and Voting Rights Details Voting Rights Shares Regulatory Compliance Sartorius Stedim Biotech Issued Capital
PRESS RELEASE published on 04/01/2025 at 10:33, 1 year 6 months ago Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL Sartorius Stedim Biotech S.A. in Aubagne, France declares the total number of shares and voting rights making up the issued capital as of March 31, 2025 Voting Rights Shares Sartorius Stedim Biotech France Aubagne
PRESS RELEASE published on 04/01/2025 at 10:31, 1 year 6 months ago Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL Sartorius Stedim Biotech SA announces total number of shares, theoretical voting rights, and net voting rights as of March 31, 2025 Voting Rights Capital Shares Sartorius Stedim Biotech SA Announcement
BRIEF published on 03/25/2025 at 15:40, 1 year 7 months ago Sartorius Stedim Biotech Shareholders Approve Key Resolutions Board Of Directors Leadership Changes Shareholders' Meeting Sartorius Stedim Biotech Dividend Approval
PRESS RELEASE published on 03/25/2025 at 15:35, 1 year 7 months ago Resolutions of the Combined Annual Shareholders’ Meeting of Sartorius Stedim Biotech S.A. Sartorius Stedim Biotech S.A. shareholders pass resolutions at Annual Shareholders' Meeting, elect new Board Members, and approve dividend payout. Company overview and financial calendar included Board Members Financial Calendar Shareholders' Meeting Sartorius Stedim Biotech Dividend Payout
BRIEF published on 03/05/2025 at 10:56, 1 year 7 months ago Sartorius Stedim Biotech Reports Share Capital and Voting Rights Share Capital Voting Rights Regulatory Compliance French Regulations Sartorius Stedim
Published on 10/30/2026 at 23:35, 1 day 5 hours ago Prospect Ridge Announces Closing of Critical Metals Flow-through Unit Private Placement
Published on 10/30/2026 at 23:30, 1 day 5 hours ago Revolve Enters into Definitive Agreement to Acquire Three Project, 6 MW Battery Storage Portfolio in Ontario
Published on 10/30/2026 at 19:00, 1 day 10 hours ago Electric Royalties Ltd. Announces Application for Warrant Extension
Published on 10/30/2026 at 15:30, 1 day 13 hours ago Bluejay Diagnostics Announces 1-for-4 Reverse Stock Split
Published on 11/01/2026 at 05:00, 29 minutes ago 2026 Yangtze River Culture Festival Opens in Yonglian Village, Zhangjiagang, Jiangsu
Published on 10/31/2026 at 16:35, 12 hours 54 minutes ago SKYWORTH Solar Announces Global Launch of Solavita as a Smart Microgrid Brand
Published on 10/30/2026 at 22:49, 1 day 6 hours ago EQS-Adhoc: STRATEC SELLS LOSS-MAKING BUSINESS, RECOGNIZES IMPAIRMENTS, AND AMENDS GUIDANCE
Published on 10/30/2026 at 23:00, 1 day 6 hours ago BIOPHYTIS REPORTS FIRST- HALF 2026 RESULTS AND PROVIDES AN UPDATE ON ITS STRATEGY
Published on 10/30/2026 at 12:00, 1 day 17 hours ago Capital increase through exercise of subscription rights
